In the published article, there was an error in affiliation Number 1. Instead of “Department of Experimental Oncology, Istituto Europeo di Oncologia, Milan, Italy”, it should be “Department of Experimental Oncology, IRCCS Istituto Europeo di Oncologia, Milan, Italy”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
single-cell sequencing, myelodysplastic syndromes, acute myeloid leukemia, clonal hematopoiesis, immunotherapies, immune microenvironment
Citation
Caprioli C, Nazari I, Milovanovic S and Pelicci PG (2022) Corrigendum: Single-cell technologies to decipher the immune microenvironment in myeloid neoplasms: Perspectives and opportunities. Front. Oncol. 12:974476. doi: 10.3389/fonc.2022.974476
Received
21 June 2022
Accepted
01 August 2022
Published
15 August 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Caprioli, Nazari, Milovanovic and Pelicci.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pier Giuseppe Pelicci, piergiuseppe.pelicci@ieo.it
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.